Multiple sclerosis: Serum anti-CNS autoantibodies - John W Prineas

Pathophysiology of multiple sclerosis - Wikipedia

Multiple sclerosis: Serum anti-CNS autoantibodies - John W Prineas, John D.E Parratt, 2018

Established and novel disease‐modifying treatments in multiple sclerosis - Cross - 2014 - Journal of Internal Medicine - Wiley Online Library

Oligodendrocytes and the early multiple sclerosis lesion - Prineas - 2012 - Annals of Neurology - Wiley Online Library

Oligodendrocytes and the early multiple sclerosis lesion - Prineas - 2012 - Annals of Neurology - Wiley Online Library

Multiple Sclerosis: Current Pathophysiological Concepts

Therapy in clinical practice (Section IV) - Multiple Sclerosis Therapeutics

PDF) Defining distinct features of anti-MOG antibody associated central nervous system demyelination

Oligodendrocytes and the early multiple sclerosis lesion - Prineas - 2012 - Annals of Neurology - Wiley Online Library

Biomedicines, Free Full-Text

Oligodendrocytes and the early multiple sclerosis lesion - Prineas - 2012 - Annals of Neurology - Wiley Online Library

Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis

Multiple sclerosis (Chapter 10) - Translational Neuroscience

A backpack-based myeloid cell therapy for multiple sclerosis

IDA-7,-8,-10. Blood vessels (a) in the small bowel and (b) in the